KARLA TENNANT: Open Payments
NPI 1407522550 · BENTON HARBOR, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,764 in 84 payments from 13 companies in 2025. Trend: 2023 $1,124 · 2024 $1,571 · 2025 $1,764
Food & beverage: $1,764
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 21 | $445 |
| E.R. Squibb & Sons, L.L.C. | 20 | $378 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $280 |
| Vanda Pharmaceuticals Inc. | 9 | $151 |
| Alkermes, Inc. | 5 | $103 |
| Janssen Pharmaceuticals, Inc | 4 | $87 |
| Axsome Therapeutics, Inc. | 4 | $83 |
| Otsuka America Pharmaceutical, Inc. | 4 | $67 |
| Supernus Pharmaceuticals, Inc. | 3 | $54 |
| Corium, LLC | 3 | $52 |
Products named: INGREZZA, COBENFY, CAPLYTA, FANAPT, ARISTADA, Auvelity, REXULTI, INVEGA SUSTENNA.
Industry payments across MI — which companies pay providers there.
